Gene: FAM234B
Official Full Name: family with sequence similarity 234 member Bprovided by HGNC
Gene Summary: Predicted to be located in Golgi apparatus; membrane; and microtubule organizing center. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17722 | FAM234B Knockout cell line (HeLa) | Human | FAM234B | 1:3~1:6 | Negative | Online Inquiry |
KO17723 | FAM234B Knockout cell line (HCT 116) | Human | FAM234B | 1:2~1:4 | Negative | Online Inquiry |
KO17724 | FAM234B Knockout cell line (HEK293) | Human | FAM234B | 1:3~1:6 | Negative | Online Inquiry |
KO17725 | FAM234B Knockout cell line (A549) | Human | FAM234B | 1:3~1:4 | Negative | Online Inquiry |
FAM234B Gene Knockout Cell Lines are expertly engineered cellular systems designed for the functional study of the FAM234B gene, a previously less characterized gene implicated in various biological processes and pathologies. These cell lines utilize CRISPR-Cas9 technology to create precise, complete deletions of the FAM234B gene, allowing for the exploration of its roles in cell biology, gene regulation, and disease mechanisms.
Key functions of FAM234B Gene Knockout Cell Lines include enabling researchers to investigate cellular pathways influenced by the absence of FAM234B, thus facilitating the understanding of its impact on cellular proliferation, differentiation, and apoptosis. The knockout model provides a straightforward approach to dissecting biological processes and developing hypotheses regarding the potential involvement of FAM234B in diseases such as cancer, neurodegenerative disorders, or metabolic syndromes.
The scientific significance of employing these knockout cell lines lies in their application across research and clinical contexts, allowing for the identification of therapeutic targets, validation of drug efficacy, and development of personalized medicine strategies. Furthermore, they serve as valuable tools in functional genomics, gene therapy research, and pathway analysis.
Compared to traditional transient transfection methods or RNA interference approaches, FAM234B Gene Knockout Cell Lines offer the advantage of stable, complete loss-of-function models that persist over multiple passages, thereby providing more consistent and reproducible results. Researchers can have confidence in the robustness and reliability of results generated from these cell lines.
For researchers and clinicians seeking to explore innovative avenues in gene function characterization or disease modeling, FAM234B Gene Knockout Cell Lines represent a significant advancement in cellular research toolkits. These products not only allow for enhanced experimental designs but are also backed by our company’s commitment to producing high-quality, reliable biological products enriched by our extensive research expertise.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.